events.jpg
-

AGHRB: Malaria vaccine implementation studies in Africa| UK Research and Innovation

NU Campus

Apply for funding to undertake implementation research to understand the optimal strategies for roll-out and scale up of the malaria vaccines RTS,S and R21 to ensure that they are deployed in the most effective and equitable way for population health benefit. Research should be conducted in at least two Sub-Saharan African countries, one of which should have a high malaria burden. We will accept applications of all sizes, including large research projects and small to medium-scale applications.

You must first submit a pre-application to apply for this funding opportunity. Following MRC confirmation your project is within remit, you will be invited to submit a full application.

clock  DeadLine

21-March-24

clock  Funding Agency

AGHRB: Malaria vaccine implementation studies in Africa| UK Research and Innovation